secwatch.observer — SEC 8-K summary
======================================

Issuer:     Microbot Medical Inc. (MBOT)
CIK:        0000883975
Form:       8-K
Filed at:   2025-11-26T23:59:59+00:00
Accession:  0001493152-25-025069
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Microbot Medical's LIBERTY robotic system adopted by Emory University Hospital as first hospital worldwide
--------------------------------------------------------------------------------

- Emory University Hospital in Atlanta is first hospital globally to adopt Microbot's LIBERTY Endovascular Robotic System for patient care.
- Microbot and Emory collaborate to establish an Endovascular Robotics Program in interventional radiology.
- LIBERTY is FDA-cleared, single-use, remotely operated robotic system designed to reduce radiation exposure and physical strain.
- Company launched limited market release weeks ago; full market release expected at SIR conference in April 2026.
- Emory will use LIBERTY for procedures including liver tumor embolization, prostate artery embolization, and uterine fibroid embolization.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883975/000149315225025069/0001493152-25-025069-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883975/000149315225025069/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-025069

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer